- Patent Title: HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
-
Application No.: US16715758Application Date: 2019-12-16
-
Publication No.: US11304997B2Publication Date: 2022-04-19
- Inventor: Tomoya Miyakawa , Masaaki Oka , Shoichi Hazama , Koji Tamada , Keiko Udaka
- Applicant: CYTLIMIC INC.
- Applicant Address: JP Tokyo
- Assignee: CYTLIMIC INC.
- Current Assignee: CYTLIMIC INC.
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2014-206730 20141007
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K7/06 ; C12N15/09 ; A61K38/00 ; A61K47/50
Abstract:
The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 15 and consisting of 11 or less amino acid residues.
Information query
